As a part of our process, you will need to complete an online health screening with our telehealth providers to ultimately determine whether you are eligible to be prescribed compounded GLP-1/GIP injections
Safety considerations of semaglutide in the potential treatment of Alzheimers disease: a pooled analysis of semaglutide in adults aged 65 years
If you anticipate needing timely answers about side effects, dose adjustments, shipping issues, or billing questions, Willow track record suggests you may be frustrated
GLP-1 Agonists For Obesity Weight loss medications are approved for adults with obesity (BMI of 30 kg/m2 or more) or overweight (BMI of 27 kg/m2 or more) with a weight-related comorbidity, including high blood pressure, type 2 diabetes, or high cholesterol
While this is indicative of how obesity and its treatment were seen at the time, I believe the sentiment is shifting as our knowledge of obesity improves, and our understanding that obesity is a progressive and relapsing disease worthy of high quality treatments and care grows